Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
NCT03056482
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Cannabis Use Disorder
Interventions
DRUG:
Ondansetron 8mg
DRUG:
Haloperidol 0.05mg/kg
DRUG:
Haloperidol 0.1mg/kg
Sponsor
Dr. Marco L.A. Sivilotti